HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ipsen Weighing Consumer Business Sale After Challenging 2020

Executive Summary

Ipsen CEO David Loew has kicked off a strategic review of the company's "non core" Consumer Healthcare business, which has endured a particularly tough year thanks to the COVID-19 pandemic.

You may also be interested in...



France’s Mayoly Spindler Set To Acquire Ipsen’s Consumer Business

Mayoly Spindler is stepping up its presence in the self-care market with the acquisition of Ipsen's Consumer Healthcare business, which has been under strategic review for the past year.

EU Q3 Results Round-Up: Karo Pharma, Probi, Ipsen

Round-up of Q3 sales and earnings results for European health and wellness players, featuring Karo Pharma, Probi and Ipsen.

Euro Results Round-Up: Alliance Pharma, Boiron And Ipsen

Round-up of Q2 and H1 financial results from three Europe-based consumer health companies: Alliance Pharma, Ipsen and Boiron.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel